Prostate News Archive
01-May-2011
FDA Approves Prostate Cancer Drug Zytiga
Title: FDA Approves prostate Cancer Drug Zytiga Category: Health News Created: 4/29/2011 11:01:00 AM Last Editorial Review: 4/29/2011 Zytiga Approved for Advanced Prostate Cancer
FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone acetate), used in combination with the steroid prednisone, has been approved to treat advanced prostate cancer, the U.S. Food and Drug Administration said in a news release. FDA Approves Advanced Prostate Cancer Drug
U.S. health regulators on Thursday approved a Johnson & Johnson (JNJ.N) drug for advanced prostate cancer considered one of the most important medicines that the company had been developing Prostate Cancer
Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around the urethra, the tube that carries urine out of the body. Tissue spacers reduce risk of rectal injury for prostate cancer patients
( American Society for Radiation Oncology ) Injecting a tissue spacer in the prostate-rectal inter-space is an effective way to reduce the rectal dose for prostate cancer patients receiving radiation therapy, according to research presented April 30, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is sponsored by the American Society for Radiation Oncology ...
Back to Prostate News Archive
